Dashboard

Intellia Therapeutics, Inc.

NTLANASDAQ

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$1.5B

Price$10.7352w $7.16 – $27.98

Conviction3/ 5

Revenue (TTM)$66M

Revenue growth YoY+45.0%

P/E (trailing)—

Gross margin-153.7%

Operating margin-636.6%

Net margin-597.0%

52w price change+49.9%

Next earningsAug 6, 2026

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

Jul 24
Ownership changeSEC
SEC Form 4 filing reporting change in beneficial ownership by insider.
Jul 6
Ownership changeSEC
SEC Form 4 filing reporting change in beneficial ownership.
Jul 6
Ownership changeSEC
SEC Form 4 insider beneficial ownership change filing.
Jun 15
OtherSEC
SEC 8-K filing (items 7.01, 8.01, 9.01)
Jun 10
Ownership changeSEC
SEC Form 4 filing for insider ownership transaction
Jun 10
Ownership changeSEC
Form 4 filing reporting change in beneficial ownership.
Jun 10
Ownership changeSEC
Form 4 filing reporting change in beneficial ownership.
Jun 10
Ownership changeSEC
SEC Form 4 insider transaction filing.
Jun 10
Ownership changeSEC
SEC Form 4 insider transaction filing.
Jun 10
Ownership changeSEC
SEC Form 4 filing reporting change in beneficial ownership by NTLA insider.
Jun 10
Ownership changeSEC
SEC Form 4 insider transaction filing.
Jun 10
OtherSEC
8-K item 5.07 filing on results of matters submitted to shareholder vote.
May 11
Financial resultsSEC
8-K filing (items 2.02, 9.01) disclosing financial results.

Not financial advice — research and opinion only. Disclosures